Effectiveness of roflumilast, a phosphodiesterase type-4 (PDE4) inhibitor on biomarkers of inflammation in COPD

被引：0
|
作者：
Savelikhina, Iryna [1 ]
Ostrovskyy, Mykola [1 ]
Zuban, Alla [1 ]
Varunkiv, Oleksandr [1 ]
Kulynych-Miskiv, Mariana [1 ]
Shvets, Kostiantyn [1 ]
Korzh, Galyna [1 ]
Makoyda, Iryna [1 ]
Korzh, Nadiia [1 ]
Shevchuk-Budz, Uliana [1 ]
机构：
[1] Ivano Frankivsk Natl Med Univ, Ivano Frankivsk, Ukraine
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA1306
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reduction in systemic inflammation by the PDE4 inhibitor roflumilast in patients with COPD
    -Martin, Eduardo Marquez
    Ruiz, Francisco Ortega
    Campano, Elena
    De la Horra, Carmen
    Varela, Jose Manuel
    Calderon, Enrique
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] Reduction in Systemic Inflammation by the PDE4 Inhibitor Roflumilast in Patients With COPD
    Marquez-martin, Eduardo
    Ortega, Francisco
    Campano, Elena
    de la Horra, Carmen
    Varela, Jose
    Calderon, Enrique
    CHEST, 2013, 144 (04)
  • [3] Pharmacokinetic characteristics of the selective phosphodiesterase 4 (PDE4)-inhibitor roflumilast
    Bethke, T. D.
    Lahu, G.
    Moll-Schueler, I.
    Gleiter, C. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (21-22) : A59 - A59
  • [4] Pharmacokinetic characteristics of the selective phosphodiesterase 4 (PDE4)-inhibitor roflumilast
    Bethke, T. D.
    Lahu, G.
    Gooss, A.
    Gleiter, C. H.
    SWISS MEDICAL WEEKLY, 2010, 140 (13-14) : 13S - 14S
  • [5] COPD: PDE4 inhibitor Roflumilast - from the symptom to the disease interference
    不详
    MEDIZINISCHE KLINIK, 2006, 101 (12) : XI - XII
  • [6] Safety of the PDE4 inhibitor roflumilast in COPD patients with chronic bronchitis
    Pohl, W.
    Sweilem, M.
    Voves, R.
    Jamnig, H.
    Moll-Schueler, I.
    Martinez, F. J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (21-22) : A58 - A58
  • [7] Efficacy of the PDE4 inhibitor roflumilast in COPD patients with chronic bronchitis
    Pohl, W.
    Sweilem, M.
    Voves, R.
    Moll-Schueler, I.
    Riesenhuber, C.
    Calverly, P. M. A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (21-22) : A57 - A58
  • [8] Safety of the PDE4 inhibitor roflumilast in COPD patients with chronic bronchitis
    Becker, J. C.
    Pettenkofer, J.
    Schmid-Wirlitsch, C.
    Gooss, A.
    SWISS MEDICAL WEEKLY, 2010, 140 (13-14) : 13S - 13S
  • [9] Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis
    Totani, Licia
    Amore, Concetta
    Piccoli, Antonio
    Dell'Elba, Giuseppe
    Di Santo, Angelo
    Plebani, Roberto
    Pecce, Romina
    Martelli, Nicola
    Rossi, Alice
    Ranucci, Serena
    De Fino, Ida
    Moretti, Paolo
    Bragonzi, Alessandra
    Romano, Mario
    Evangelista, Virgilio
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [10] The phosphodiesterase 4 (PDE4) inhibitor roflumilast improves remyelination in a mouse model for multiple sclerosis
    Schepers, M.
    Mailleux, J.
    Bogie, J.
    van Goethem, N.
    Hellings, N.
    Hendriks, J.
    Prickaerts, J.
    Vanmierlo, T.
    GLIA, 2017, 65 : E361 - E361
12345